Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | GSR | P00390 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9725051 | 0.84 | MEN1 (0.55) | KDM4ECYP1A2LMNAAGTR1MEN1 | |
| SCHEMBL4232165 | 0.81 | KMT2A (0.42) | KDM4ECYP1A2LMNAAGTR1MEN1 | |
| SCHEMBL28046650 | 0.81 | KDM4E (0.42) | KDM4ECYP1A2LMNAAGTR1MEN1 | |
| SCHEMBL16004867 | 0.81 | CASR (0.47) | KDM4ECYP1A2LMNAAGTR1MEN1 | |
| SCHEMBL6578270 | 0.78 | CYP1A2 (0.51) | KDM4ECYP1A2LMNAAGTR1MEN1 | |
| SCHEMBL27502251 | 0.78 | ALDH1A1 (0.51) | KDM4ECYP1A2LMNAAGTR1MEN1 | |
| SCHEMBL19798765 | 0.78 | LMNA (0.44) | KDM4ELMNAMEN1KMT2ACYP2C19 | |
| SCHEMBL18714817 | 0.77 | CASR (0.46) | KDM4ELMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL6931929 | 0.77 | CASR (0.49) | KDM4ECYP1A2LMNAAGTR1MEN1 | |
| SCHEMBL2538159 | 0.77 | CYP1A2 (0.39) | KDM4ECYP1A2LMNAAGTR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210047765-A1 | PROCESS FOR TREATING OF THREADS | TWINE SOLUTIONS LTD. (IL) | 2021-02-18 | — | — | US | claimed |
| EP-3721005-A1 | PROCESS FOR TREATING OF THREADS | Twine Solutions Ltd. (IL) | 2020-10-14 | — | — | EP | claimed |
| JP-4587669-B2 | — | — | 2010-11-24 | — | — | JP | claimed |
| US-20100209374-A1 | Multi-Phase Personal Care Composition Comprising a Stabilizing Perfume Composition | WEI KARL SHIQING | 2010-08-19 | — | — | US | claimed |
| US-7700528-B2 | Multi-phase personal care composition comprising a stabilizing perfume composition | THE PROCTER & GAMBLE COMPANY (US) | 2010-04-20 | — | — | US | claimed |
| EP-1942861-A2 | MULTI-PHASE PERSONAL CARE COMPOSITION COMPRISING A STABILIZING PERFUME COMPOSITION | The Procter and Gamble Company (US) | 2008-07-16 | — | — | EP | claimed |
| US-20070135319-A1 | Multi-phase personal care composition comprising a stabilizing perfume composition | PROCTER & GAMBLE COMPANY, THE | 2007-06-14 | — | — | US | claimed |
| WO-2007052224-A2 | MULTI-PHASE PERSONAL CARE COMPOSITION COMPRISING A STABILIZING PERFUME COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2007-05-10 | — | — | WO | claimed |
| JP-2005509662-A | — | — | 2005-04-14 | — | — | JP | claimed |
| EP-1443915-A1 | PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING OXY GROUP-BEARING AROMATIC ALDEHYDES | Cutanix Corporation (US) | 2004-08-11 | — | — | EP | claimed |
| US-20030157154-A1 | Compositions containing hydroxy aromatic aldehydes and their use in treatments | CUTANIX CORPORATION | 2003-08-21 | — | — | US | claimed |
| WO-2003043621-A1 | PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING OXY GROUP-BEARING AROMATIC ALDEHYDES | CUTANIX CORPORATION (US) | 2003-05-30 | — | — | WO | claimed |
| US-20030036489-A1 | Consumable composition comprising perfumed particles and article containing the same | THE PROCTER & GAMBLE COMPANY | 2003-02-20 | — | — | US | claimed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| WO-2002090481-A1 | COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| US-20250302014-A1 | WASP PEST MANAGEMENT SYSTEM | TONER DARADH (IE) | 2025-10-02 | — | — | US | disclosed |
| EP-4518647-A1 | WASP PEST MANAGEMENT SYSTEM | Toner, Daradh (IE) | 2025-03-12 | — | — | EP | disclosed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | disclosed |
| WO-2002089862-A2 | AIR FRESHENING COMPOSITIONS, ARTICLES COMPRISING SAME AND METHODS FOR PREPARING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | disclosed |
| US-5277919-A | Food processing | WM. WRIGLEY JR. COMPANY (US) | 1994-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030157154-A1 | Compositions containing hydroxy aromatic aldehydes and their use in treatments | TYR, HRH1, HRH2 | KDM4E 2158/4885CYP1A2 223/4885LMNA 3446/4885 |
| US-20070135319-A1 | Multi-phase personal care composition comprising a stabilizing perfume composition | CUTA, PARG, POLG | KDM4E 4592/4885CYP1A2 4448/4885LMNA 731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.